Sudden cardiac death, a common cause of cardiac mortality, can be treated with either pharmacologic therapy or implantation of an implantable cardioverter defibrillator. Tremendous technologic advances have changed implantable cardioverter defibrillator therapy from shock-only therapy to multiprogrammable, tiered-therapy devices with backup pacing. Methods of implantation have changed from open chest to non-thoracotomy procedures. To provide optimal patient care, the critical care nurse is challenged to be knowledgeable about the different devices. In this article, the authors examine the commonalities and differences in device function in the seven currently available implantable cardioverter defibrillators and their impact on patient care
Skip Nav Destination
Article navigation
1 February 1995
Physiologic Monitoring|
February 01 1995
Update on Implantable Cardioverter Defibrillators: Knowing the Differences in Devices and Their Impact on Patient Care
Kay Nichols, RN, MS, CCRN;
*From the Riverside Methodist Hospitals, Columbus, Ohio.
Reprint requests to Kay Nichols, RN, MS, CCRN, 2126 Sandover Ct., Columbus, OH 43220.
Search for other works by this author on:
Janet Collins, RN, MS
Janet Collins, RN, MS
†From the Ohio State University Hospital, Columbus, Ohio.
Search for other works by this author on:
AACN Adv Crit Care (1995) 6 (1): 31–43.
Citation
Kay Nichols, Janet Collins; Update on Implantable Cardioverter Defibrillators: Knowing the Differences in Devices and Their Impact on Patient Care. AACN Adv Crit Care 1 February 1995; 6 (1): 31–43. doi:
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
1
Views